Hextar Healthcare BhdXKLS:7803 +9.09% Days Payable is 23.75 as of Mar. 2026, which is 60% below its 10-year median of 59.17. The stock has 3 warning signs investors should review. Among 1,556 Chemicals companies, Hextar Healthcare Bhd ranks worse than 79.56% on this metric.
Hextar Healthcare Bhd Days Payable Historical Data
* Premium members only.
The historical data trend for Hextar Healthcare Bhd's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7803 vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's Days Payable distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Hextar Healthcare Bhd's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hextar Healthcare Bhd (XKLS:7803) has a Days Payable of 23.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hextar Healthcare Bhd and its competitors. This is 60% below median its historical median of 59.17. Over the past decade, Hextar Healthcare Bhd's Days Payable has ranged from 22.32 to 147.09. According to the industry distribution chart, Hextar Healthcare Bhd ranks #1238 out of 1556 companies in the Chemicals industry, placing it in the top 79.6%.
Is Hextar Healthcare Bhd's Days Payable too high?
Hextar Healthcare Bhd's current Days Payable of 23.75 is 60% below median its 10-year median of 59.17. Over the past 10 years, this metric has ranged from a low of 22.32 to a high of 147.09. The Chemicals industry median Days Payable is 59.92. Hextar Healthcare Bhd's value of 23.75 is 60.4% below this industry median. Based on the distribution chart, Hextar Healthcare Bhd ranks #1238 out of 1556 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Hextar Healthcare Bhd's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #1238 out of 1556 companies for Days Payable. This places Hextar Healthcare Bhd in the lower half of its industry. The industry median Days Payable is 59.92. Hextar Healthcare Bhd's value of 23.75 is 60.4% below this benchmark. Historically, Hextar Healthcare Bhd's own Days Payable has ranged from 22.32 to 147.09 over the past decade. While the company's 10-year median is 59.17 vs. the industry median of 59.92, Hextar Healthcare Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.92, based on 1,556 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hextar Healthcare Bhd's current Days Payable of 23.75 is 60.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median Days Payable is 59.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current Days Payable is 23.75, which is 60% below median its own 10-year median of 59.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.16, compared to a current price of RM0.06 — trading 62.5% below its estimated fair value. The current Days Payable is 23.75, which is 60% below median its 10-year median of 59.17 and 60.4% below the Chemicals industry median of 59.92. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Days Payable is 23.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 